Giant Cell Astrocytoma
Oncology·MeSH: Neurofibroma, Plexiform
Prevalence
5.0 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| afinitor | Novartis AG (NVS) |
Frequently asked questions
How many drugs are in development for Giant Cell Astrocytoma?
BioSniper tracks 1 drug in development for Giant Cell Astrocytoma across 1 company.
How many clinical trials target Giant Cell Astrocytoma?
There are 1 clinical trial targeting Giant Cell Astrocytoma tracked by BioSniper.
What is the prevalence of Giant Cell Astrocytoma?
The estimated prevalence of Giant Cell Astrocytoma is approximately 5.0 per 100,000 population.
Deep-dive into Giant Cell Astrocytoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis